Nanopartz Customer Spotlight
August 2023 Quantum Photonics on a Tapered Optical Fiber For the first time, Scientist Ji Won Ha from Tokyo Japan used tapered optical fiber with subwavelength diameter waist, an optical nanofiber, providing a unique and all-fiber platform for manipulating atoms and photons. They demonstrated a polarized fiber-in-line quantum light source using a hybrid system of a single Nanopartz gold nanorod and single quantum dot deposited on a nanofiber.
|
December 2023 Transfer Printing of Ordered Plasmonic Nanoparticles Scientists from the the Dept of Biological Engineering at Utah State University have demonstrated for the first time, a high yield across a large area, an optical surface lattice resonance on glass substrates.
|
December 2020 For the first time, scientists from the University of Michigan have developed an imaging technique that can visualize newly developed blood vessels in the back of the eye, named choroidal neovascularization (CNV).
|
February 2021 Control of Light Transmission in a Plasmonic Liquid Metacrystal Scientists from the Institut Jean Lamour (CNRS - Université de Lorraine) experimentally demonstrated the control of light transmission through a slab of plasmonic liquid metacrystal by an external electric field.
|
July 2020 Electrically-Driven Yagi-Uda Antennas for Light For the first time, physicists from the University of Würzburg have successfully converted electrical signals into photons and radiated them in specific directions using a low-footprint optical antenna that is only 800 nanometers in size. At the heart of this structure is a single CTAB-coated gold nanoparticle from Nanopartz.
|
September 2020 Gold Nanoparticle Mediated Multi-Modal CT Imaging of Hsp70 Membrane-Positive Tumors For the first time, scientists from the Technical University of Munich have successfully utilized membrane-Hsp70 functionalized Gold-Nanoparticles for tumor-specific spectral CT imaging in preclinical settings. As the central element of this study, PEG-amine-coated gold nanoparticles from Nanopartz were used, which were further functionalized with anti-membrane Hsp70 antibodies, rendering them highly tumor-specific for in vivo applications.
|
